Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Authors
Keywords
-
Journal
RESPIROLOGY
Volume 23, Issue 1, Pages 36-45
Publisher
Wiley
Online
2017-08-29
DOI
10.1111/resp.13143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil
- (2017) Margareth Dalcolmo et al. EUROPEAN RESPIRATORY JOURNAL
- An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
- (2017) Mayara Lisboa Bastos et al. EUROPEAN RESPIRATORY JOURNAL
- Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation
- (2017) Chongguang Yang et al. LANCET INFECTIOUS DISEASES
- Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?
- (2017) Yanina Balabanova et al. THORAX
- Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
- (2017) Emily A Kendall et al. Lancet Respiratory Medicine
- Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Precision Public Health for the Era of Precision Medicine
- (2016) Muin J. Khoury et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
- (2016) Christoph Lange et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis
- (2016) Shanshan Wu et al. AMERICAN JOURNAL OF THERAPEUTICS
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elucidating the role of clofazimine for the treatment of tuberculosis
- (2016) M. R. O'Donnell et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study
- (2016) M. Bonnet et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
- (2016) Mishal Pandie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- WHO recommendations on shorter treatment of multidrug-resistant tuberculosis
- (2016) Giovanni Sotgiu et al. LANCET
- Tuberculosis
- (2016) Keertan Dheda et al. LANCET
- Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
- (2016) Matteo Zignol et al. LANCET INFECTIOUS DISEASES
- β-Lactams against Tuberculosis — New Trick for an Old Dog?
- (2016) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
- (2015) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The need to accelerate access to new drugs for multidrug-resistant tuberculosis
- (2015) Helen S Cox et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa
- (2015) M. Loveday et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
- (2015) N. Ndjeka et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
- (2015) C. Kuaban et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Linezolid for XDR-TB — Final Study Outcomes
- (2015) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies
- (2015) Ekaterina V Kurbatova et al. Lancet Respiratory Medicine
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug
- (2014) Sarah C. McLeay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection
- (2014) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment: TABLE 1
- (2014) Akos Somoskovi et al. EUROPEAN RESPIRATORY JOURNAL
- Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients
- (2014) K. J. M. Aung et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
- (2014) A. Piubello et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
- (2014) Elize Pietersen et al. LANCET
- Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
- (2014) Marylee V. Worley et al. PHARMACOTHERAPY
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
- (2014) Thomas J Hwang et al. BMJ Open
- Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
- (2014) Thomas J. Hwang et al. PLOS MEDICINE
- High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers
- (2013) Max R. O'Donnell et al. ANNALS OF INTERNAL MEDICINE
- Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
- (2013) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis [Review article]
- (2013) T. J. Hwang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Epidemiology: A mortal foe
- (2013) Tom Paulson NATURE
- What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
- (2013) Anil Pooran et al. PLoS One
- Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients
- (2013) Martha Van der Walt et al. PLoS One
- Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis [Review article]
- (2012) A. Toczek et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- African Perceptions of Female Attractiveness
- (2012) Vinet Coetzee et al. PLoS One
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
- (2011) Nicolas Veziris et al. PLoS One
- Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis
- (2011) Masja Straetemans et al. PLoS One
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search